Advanced Search

 

Study ID Status Title Patient Level Data
107291 Completed A phase IIIb, double-blind, randomized, controlled study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine, administered intramuscularly in healthy female subjects aged 15 – 25 years Study Listed on ClinicalStudyDataRequest.com
107336 Completed Safety and immunogenicity study of the HPV vaccine (GSK-580299) in healthy, Chinese, female subjects Study Listed on ClinicalStudyDataRequest.com
107434 Completed A randomised, double-blind, double-dummy, placebo controlled, three-way cross-over study to investigate the effect of single oral doses of 100 mg GW273225 (4030W92) and 325 mg LAMICTAL on resting motor threshold in healthy subjects Study Listed on ClinicalStudyDataRequest.com
107495 Completed Reactogenicity and Immunogenicity Study of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1119711A) Administered According to Different Vaccination Schedules Study Listed on ClinicalStudyDataRequest.com
107507 Completed A Phase III study for evaluation of immunogenicity and reactogenicity of Fluarix™ (Influsplit SSW®) 2006/2007 in people aged 18 years or above Study Listed on ClinicalStudyDataRequest.com
107531 Completed Assess the immunogenicity of 3 doses of Pediarix®, Prevnar® & ActHIB® given to healthy infants when administered with GSK Biologicals’ 2 dose oral live attenuated human rotavirus vaccine given during the same vaccination visit or separately Study Listed on ClinicalStudyDataRequest.com
107564 Completed An observational study to investigate the incidence of influenza and influenza-related complications, in adults between 50-64 years and elderly adults 65 years and over vaccinated with Fluarix™ Study Listed on ClinicalStudyDataRequest.com
107625 Completed Efficacy, safety, reactogenicity and immunogenicity study of the lyophilised formulation of Rotarix vaccine in healthy Japanese infants Study Listed on ClinicalStudyDataRequest.com
107671 Terminated Study EGF107671 – a Phase II Study of Lapatinib plus Topotecan or Lapatinib plus Capecitabine in the Treatment of Recurrent Brain Metastases from ErbB2-Positive Breast Cancer Following Cranial Radiotherapy
107682 Completed A randomized, open study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ HPV vaccine Co-administered intramuscularly with Boostrix® and/or Menactra™ in healthy female subjects aged 11–18 years Study Listed on ClinicalStudyDataRequest.com
107706 Completed To assess safety, reactogenicity & immunogenicity of a booster dose of pneumococcal conjugate vaccine, co-admin with GSK Biologicals’ MMRV vaccine in children (2nd yr of life) primed with the pneumococcal conjugate vaccine in study 105553. Study Listed on ClinicalStudyDataRequest.com
107731 Completed Adjuvant justification study of candidate malaria vaccines (257049), administered according to a 0, 1, 2 months schedule . Study Listed on ClinicalStudyDataRequest.com
107737 Completed Study to assess the safety and immunogenicity of GSK Biologicals 10-valent pneumococcal conjugate vaccine when Co-administered with DTPa-HBV-IPV/Hib (Infanrix-Hexa) vaccine in preterm infants as a 3-dose primary immunization course during the first 6 months of life. Study Listed on ClinicalStudyDataRequest.com
107806 Completed An open label study to determine the safety, tolerability, excretion balance and pharmacokinetics of [14C]GW856553, administered as a single dose of an oral solution to healthy adult male subjects.
107824 Completed A study to evaluate the long-term antibody persistence at 1, 3 & 5 years after the administration of a fourth dose of Hib-MenCY-TT Vaccine compared to ActHIB in subjects boosted in a previous study. Study Listed on ClinicalStudyDataRequest.com
107863 Completed Evaluation of the safety and immunogenicity of GlaxoSmithKline Biologicals' HPV vaccine 580299 (Cervarix TM) in adult human immunodeficiency virus (HIV) infected female subjects Study Listed on ClinicalStudyDataRequest.com
107876 Completed Study to evaluate clinical consistency of the liquid formulation of GSK Biologicals' HRV vaccine and to evaluate liquid formulation compared to lyophilised formulation of the HRV vaccine administered as a two-dose primary vaccination. Study Listed on ClinicalStudyDataRequest.com
107924 Completed Open, booster vaccination study to assess safety and reactogenicity of GSK Biologicals’ dTpa vaccine (Boostrix) when administered to healthy chinese children 6-8 years of age. Study Listed on ClinicalStudyDataRequest.com
107975 Completed A study to evaluate the immunogenicity, safety and reactogenicity of adjuvanted influenza vaccine candidate compared to Fluarix™ (GlaxoSmithKline Biologicals) administered intramuscularly in elderly aged 60 years and older. Study Listed on ClinicalStudyDataRequest.com
107979 Completed TXA107979: A Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of a Combination Product Containing Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine in Adolescents Study Listed on ClinicalStudyDataRequest.com
107988 Completed A Dose Rising Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Oral Doses of the Enteric-Coated Free Base Formulation of SB-480848 in Healthy Adult Subjects
108134 Completed A study to demonstrate the efficacy of GSK Biologicals’ influenza vaccine (Fluarix™) administered intramuscularly in adults Study Listed on ClinicalStudyDataRequest.com
108251 Completed Evaluate immunogenicity & safety of a single or double-dose of the pandemic influenza candidate vaccine (GSK1562902A) given following a two-administration schedule (21 days apart) in adults over 60 yrs Study Listed on ClinicalStudyDataRequest.com
108251 Completed Evaluate immunogenicity & safety of a single or double-dose of the pandemic influenza candidate vaccine (GSK1562902A) given following a two-administration schedule (21 days apart) in adults over 60 yrs Study Listed on ClinicalStudyDataRequest.com
108251 Completed Evaluate immunogenicity & safety of a single or double-dose of the pandemic influenza candidate vaccine (GSK1562902A) given following a two-administration schedule (21 days apart) in adults over 60 yrs Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.